Related Experiment Video
Updated: Jul 19, 2026
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Drug neosensitization during anticonvulsant hypersensitivity syndrome
P Gaig1, P García-Ortega, M Baltasar
1Allergy Unit, Hospital Universitari Joan XXIII, Tarragona, Spain. pgaigj@hjxxiii.scs.es
Journal of Investigational Allergology & Clinical Immunology
|October 17, 2006
Summary
Anticonvulsant hypersensitivity syndrome (AHS) can lead to new drug allergies. Patients previously treated for DRESS may develop hypersensitivity to other medications, highlighting the need for careful allergy evaluation.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Anticonvulsant hypersensitivity syndrome (AHS), a severe drug reaction, is linked to Drug-Related Rash with Eosinophilia and Systemic Symptoms (DRESS).
- AHS is characterized by transient immunosuppression and potential reactivation of latent viral infections.
Observation:
- Five patients previously experiencing anticonvulsant-related DRESS developed neosensitization to different drugs.
- Diagnostic allergy testing, including skin prick, intradermal, and patch tests, confirmed drug hypersensitivity in these patients.
- One patient exhibited transient hypogammaglobulinemia during AHS.
Findings:
- Four out of five patients experienced delayed skin or systemic hypersensitivity reactions to drugs previously taken during anticonvulsant DRESS.
- Positive diagnostic tests included intradermal amoxicillin, paracetamol, amitriptyline patch tests, and clinical ceftriaxone erythroderma.
- Allergy workup successfully prevented a potential reaction in one patient.
Implications:
- The study suggests considering neosensitization to drugs administered during anticonvulsant-related DRESS.
- Transient immunosuppression during DRESS may trigger viral reactivation and immune system dysregulation, leading to drug tolerance breakdown.
- This highlights the importance of comprehensive allergy assessments in patients with a history of severe drug hypersensitivity reactions.
Related Concept Videos
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...